Cargando…
Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA
The promyelocytic leukemia (PML) nuclear body (also referred to as ND10, POD, and Kr body) is involved in oncogenesis and viral infection. This subnuclear domain has been reported to be rich in RNA and a site of nascent RNA synthesis, implicating its direct involvement in the regulation of gene expr...
Autores principales: | Boisvert, François-Michel, Hendzel, Michael J., Bazett-Jones, David P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174275/ https://www.ncbi.nlm.nih.gov/pubmed/10648561 |
Ejemplares similares
-
The Transcription Coactivator Cbp Is a Dynamic Component of the Promyelocytic Leukemia Nuclear Body
por: Boisvert, François-Michel, et al.
Publicado: (2001) -
Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies
por: Hirano, Seishiro, et al.
Publicado: (2022) -
Acute promyelocytic leukemia, arsenic, and PML bodies
por: de Thé, Hugues, et al.
Publicado: (2012) -
Targeting Promyelocytic Leukemia Protein: A Means to Regulating PML Nuclear Bodies
por: Reineke, Erin L., et al.
Publicado: (2009) -
Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
por: Yoon, G. S., et al.
Publicado: (2001)